scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1152/AJPGI.1983.245.5.G601 |
P953 | full work available at URL | https://www.physiology.org/doi/pdf/10.1152/ajpgi.1983.245.5.G601 |
P698 | PubMed publication ID | 6195926 |
P2093 | author name string | T. A. Miller | |
P433 | issue | 5 Pt 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | physiology | Q521 |
P304 | page(s) | G601-23 | |
P577 | publication date | 1983-11-01 | |
P1433 | published in | American Journal of Physiology | Q2160146 |
P1476 | title | Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms | |
P478 | volume | 245 |
Q67880913 | 76th General Meeting of the Japanese Society of Gastroenterology. Tokyo, Japan, March 29-31, 1990. Abstracts |
Q38974252 | A Review of Anti-Inflammatory Drug-Induced Gastrointestinal Injury: Focus on Prevention of Small Intestinal Injury |
Q41763552 | Acceleration of recovery of gastric epithelial integrity by 16,16-dimethyl prostaglandin E2. |
Q36918403 | Acute toxicity and gastroprotective role of M. pruriens in ethanol-induced gastric mucosal injuries in rats |
Q41048711 | Adaptive cytoprotection against deoxycholate-induced injury in human gastric cells in vitro: is there a role for endogenous prostaglandins? |
Q74791962 | Adaptive cytoprotection induced by ethanol in human intestinal cells: role of prostaglandins and calcium homeostasis |
Q40563667 | Adaptive cytoprotection induced by pretreatment with ethanol protects against gastric cell damage by NSAIDs |
Q34475981 | Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology |
Q44245363 | Alterations in rat intestinal mucin patterns following luminal infusion of acetylsalicylic acid and prostaglandin derivatives |
Q73222629 | Anti-ulcer actions of the bark methanol extract of Voacanga africana in different experimental ulcer models in rats |
Q38209865 | Anti-ulcer activity of essential oil constituents. |
Q45017610 | Arachidonic acid and prostaglandin E2 activate small-conductance Cl- channels in the basolateral membrane of rabbit parietal cells |
Q44596661 | Arachidonic acid does not protect against sodium taurocholate damage to rat gastric epithelial cell cultures |
Q70348829 | Arachidonic acid stimulation of mucus production by rat gastric cultured cells |
Q50893736 | Binding and biological actions of prostaglandin E2 and I2 in cells isolated from rabbit gastric mucosa. |
Q46630704 | Biochemical mechanism of healing activity of the natural phenolic, allylpyrocatechol against indomethacin-induced gastric ulceration in mice |
Q36009576 | Bombesin-induced gastroprotection |
Q44901308 | Calcium channel blockers prevent stress-induced ulcers in rats. |
Q38903808 | Cellular Energetical Actions of "Chemical" and "Surgical" Vagotomy in Gastrointestinal Mucosal Damage and Protection: Similarities, Differences and Significance for Brain-Gut Function |
Q72642786 | Cholecystokinin is a potent protective agent against alcohol-induced gastric injury in the rat. Role of endogenous prostaglandins |
Q35771324 | Cholecystokinin-induced gastroprotection: a review of current protective mechanisms |
Q51587414 | Chronic effects of misoprostol in combination with the NSAID, diclofenac, on gastrointestinal tract of pigs. Relation to diarrheagenic activity, leukocyte infiltration, and mucosal leukotrienes. |
Q34527526 | Cigarette smoking reduces human gastric luminal prostaglandin E2 |
Q70275665 | Comparative mucosal protective properties of misoprostol, cimetidine, and sucralfate |
Q26827673 | Current perspectives in NSAID-induced gastropathy |
Q74435149 | Cyclooxygenase inhibition attenuates cholecystokinin-induced gastroprotection |
Q37642691 | Cytoprotective and antioxidant effects of the methanol extract of Eremomastax speciosa in rats. |
Q42484616 | Dexamethasone makes the gastric mucosa susceptible to ulceration by inhibiting prostaglandin synthetase and peroxidase--two important gastroprotective enzymes |
Q34529371 | Dietary essential fatty acids and the decline in peptic ulcer disease--a hypothesis |
Q70043312 | Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa |
Q93557405 | Effect of non-steroidal anti-inflammatory drugs on the human small intestine |
Q72714303 | Effect of stress on the antioxidant enzymes and gastric ulceration |
Q28195499 | Effect of various doses of palm vitamin E and tocopherol on aspirin-induced gastric lesions in rats |
Q69785606 | Effects of FCE20700, a new PGE2 derivative, on gastric acid secretion and cytoprotective processes in man |
Q28361095 | Effects of S-2474, a novel nonsteroidal anti-inflammatory drug, on amyloid beta protein-induced neuronal cell death |
Q70275634 | Effects of absolute ethanol, misoprostol, cimetidine, and phosphate buffer on the morphology of rat gastric mucosae |
Q41892467 | Effects of captopril on factors affecting gastric mucosal integrity in aspirin-induced gastric lesions in Sprague-Dawley rats |
Q36415630 | Effects of extract F of red-rooted Salvia on mucosal lesions of gastric corpus and antrum induced by hemorrhagic shock-reperfusion in rats |
Q69048005 | Effects of gastric distension and prostaglandin on acid ethanol-induced mucosal lesions in the rat |
Q44922792 | Effects of granulocyte colony-stimulating factor on bacterial translocation due to burn wound sepsis |
Q73222625 | Effects of methanol, cyclohexane and methylene chloride extracts of Bidens pilosa on various gastric ulcer models in rats |
Q68479207 | Effects of milk, prostaglandin, and antacid on experimentally induced duodenitis in the rat. Use of myeloperoxidase as an index of inflammation |
Q67979100 | Effects of secretin on content of PGE2 and 6-keto PGF1 alpha in gastric mucosa |
Q35536139 | Endothelial cell growth regulation by PGE1 analog misoprostol and indomethacin |
Q34069536 | Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial. |
Q43203862 | Essential fatty acids and peptic ulcer disease |
Q68896723 | Evaluation of putative cytoprotective properties of antiulcer drugs using quantitative histological techniques |
Q69467591 | Free radicals and lipid peroxidation in ethanol- or aspirin-induced gastric mucosal injury |
Q37769451 | Gastric cytoprotection 30 years after its discovery by André Robert: a personal perspective |
Q39682730 | Gastric cytoprotection: a critical appraisal of the concept, methodology, implications, mechanisms and future research prospects |
Q53767646 | Gastric cytoprotective anti-ulcer effects of the leaf methanol extract of Ocimum suave (Lamiaceae) in rats. |
Q70378474 | Gastric mucosal blood flow in misoprostol pretreated aspirin-induced ulceration |
Q72408127 | Gastric mucosal high-energy phosphate metabolism. Influence of ethanol and PGE2 |
Q70275651 | Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study |
Q46720932 | Gastro-protective agent rebamipide induces cyclooxygenease-2 (COX-2) in gastric epithelial cells |
Q70123437 | Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate |
Q72043962 | Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance |
Q52573271 | HPLC-DAD identification of polyphenols from ethyl acetate extract of Amaranthus spinosus leaves and determination of their antioxidant and antinociceptive effects. |
Q33317631 | Healing potential of Picrorhiza kurroa (Scrofulariaceae) rhizomes against indomethacin-induced gastric ulceration: a mechanistic exploration |
Q38353541 | Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease |
Q44563908 | Inability of cytoprotection to occur during a period of gastric ischemia |
Q50508036 | Investigation of gastroprotective compounds at subcellular level in isolated gastric mucosal cells. |
Q68835838 | Isolation, culture and characterization of human peritoneal mesothelial cells |
Q70464121 | Isoproterenol prevents ethanol-induced microvascular stasis and deep histologic injury in rat gastric mucosa |
Q36684818 | Isoproterenol-induced gastric mucosal protection from bile acid. Role of endogenous prostaglandins |
Q46723164 | Low direct cytotoxicity and cytoprotective effects of nitric oxide releasing indomethacin |
Q46679816 | Low direct cytotoxicity of nabumetone on gastric mucosal cells |
Q35896167 | Mechanisms of Gastroprotective Effects of Ethanolic Leaf Extract of Jasminum sambac against HCl/Ethanol-Induced Gastric Mucosal Injury in Rats |
Q43523926 | Mechanisms of protective activity of 16,16-dimethyl PGE2 and acetazolamide on gastric and duodenal lesions in rats |
Q36072718 | Mechanistic aspects of gastric cytoprotection--a review |
Q53896533 | Misoprostol preclinical pharmacology. |
Q39540382 | Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease |
Q22251417 | Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms |
Q51585426 | Modulation of noradrenaline release in rat isolated stomach by prostanoids, but not by histaminergic mechanisms. |
Q38974315 | Molecular Mechanism for Various Pharmacological Activities of NSAIDS |
Q39764245 | Mucosal coating agents and other nonantisecretory agents. Are they cytoprotective? |
Q71833225 | Mucosal permeability after subclinical intestinal ischemia-reperfusion injury: An exploration of possible mechanisms |
Q70240147 | Mucosal prostaglandin levels of the gastric stump |
Q50906431 | N-acetyl-cysteine and prostaglandin. Comparable protection against experimental ethanol injury in the stomach independent of mucus thickness. |
Q41331940 | NSAID-induced gastrointestinal damage. Epidemiology, risk and prevention, with an evaluation of the role of misoprostol. An Asia-Pacific perspective and consensus |
Q40476391 | New insights into the mode of action of anti-inflammatory drugs |
Q72863336 | Nicotine has no effect on rat gastric mucosal prostaglandin generation in vitro |
Q40364679 | Nitrite in saliva increases gastric mucosal blood flow and mucus thickness. |
Q36282905 | Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects |
Q38627221 | Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management |
Q40754162 | Nonsteroidal anti-inflammatory drugs. Differential use in older patients |
Q42810069 | PGE2 protects isolated cells against injury through multiple mechanisms |
Q69179540 | Preventive and curative effects of prostaglandins on stress ulcer in rats. Application of endoscopic observation |
Q39253714 | Pro-ulcer effects of resveratrol in mice with indomethacin-induced gastric ulcers are reversed by L-arginine |
Q74256030 | Prophylactic and healing properties of a new anti-ulcer compound from Enantia chlorantha in rats |
Q36003997 | Prostaglandin formation by isolated gastric parietal and nonparietal cells of the rat. |
Q52495591 | Prostaglandin protection of rat colonic mucosa from damage induced by ethanol. |
Q42144808 | Prostaglandin protects against bile salt induced increases in proton permeation of duodenal brush border membrane |
Q40511876 | Prostaglandin protects isolated guinea pig chief cells against ethanol injury via an increase in diacylglycerol |
Q69960470 | Prostaglandin-induced gastric mucosal protection against stress injury. Absence of a relationship to tissue glutathione levels |
Q37373318 | Prostaglandins I2 and E2 have a synergistic role in rescuing epithelial barrier function in porcine ileum |
Q39832100 | Prostaglandins and histological changes in the gastric mucosa |
Q41345878 | Prostaglandins in peptic ulcer disease. An overview of current status and future directions |
Q40958153 | Prostaglandins protect human intestinal cells against ethanol injury by stabilizing microtubules: role of protein kinase C and enhanced calcium efflux |
Q34192889 | Prostaglandins, thromboxanes and leukotrienes in clinical medicine |
Q69995121 | Prostaglandins. A surgeon's perspective |
Q54339880 | Protection of gastric mucosa against hypertonic sodium chloride by 16,16-dimethyl prostaglandin E2 or sodium thiosulfate in the rat: evidence for decreased mucosal penetration of damaging agent. |
Q67534136 | Protective effect of 16,16-dimethyl prostaglandin E2 on isolated rat hepatocytes against complement-mediated immune attack |
Q37658800 | Protective role of HSF1 and HSP70 against gastrointestinal diseases |
Q35594597 | Recovery of ischaemic injured porcine ileum: evidence for a contributory role of COX-1 and COX-2 |
Q64914477 | Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man. |
Q71835005 | Reversion by histamine H2-receptor antagonists of plasma membrane alterations in ethanol-induced gastritis |
Q84417386 | Role of capsaicin-sensitive primary afferent neurons and non-protein sulphydryl groups on gastroprotective effect of amifostine against ethanol-induced gastric damage in rats |
Q71811783 | Role of dorsal motor nucleus of vagus in gastric function and mucosal damage induced by ethanol in rats |
Q69358530 | Role of superoxide and hydroxyl radicals in rat gastric mucosal injury induced by ethanol |
Q39571006 | Screening of Ficus religiosa leaves fractions for analgesic and anti-inflammatory activities. |
Q35584950 | Smoking and the pathogenesis of gastroduodenal ulcer--recent mechanistic update |
Q46528136 | Stimulation of electrogenic chloride secretion by prostaglandin E2 in guinea-pig isolated gastric mucosa |
Q34391987 | Stimulation of glycoprotein and protein synthesis in isolated pig gastric mucosal cells by prostaglandins |
Q42379006 | Store-operated Ca2+ Entry Facilitates the Lipopolysaccharide-induced Cyclooxygenase-2 Expression in Gastric Cancer Cells |
Q35755379 | Sulphasalazine and PhCL28A inhibit the formation of ethanol- and phenylbutazone-induced rat gastric ulcers: lack of involvement of endogenous prostaglandins? |
Q46543423 | Suppression of ethanol-induced apoptotic DNA fragmentation by geranylgeranylacetone in cultured guinea pig gastric mucosal cells |
Q26771996 | The antibacterial effect of fatty acids on Helicobacter pylori infection |
Q67568274 | The degree of bacterial translocation is a determinant factor for mortality after burn injury and is improved by prostaglandin analogs |
Q70372043 | The effects of 16,16-dimethyl prostaglandin E2 + aspirin on the canine gastric mucosal barrier |
Q69185514 | The gastric mucosal barrier: tight junction structure in gastritis and ulcer biopsies |
Q34081027 | The protective effects of sucralfate and ranitidine in foals experimentally intoxicated with phenylbutazone. |
Q33814331 | The role of cyclooxygenases in inflammation, cancer, and development |
Q42932529 | The role of erythropoietin in the protection of gastric mucosa from indometacin-induced gastric injury and its relationship with oxidant and antioxidant parameters in rats |
Q37905581 | The use of vasopressin in the treatment of upper gastrointestinal haemorrhage |
Q93513487 | Theoretical mechanism for the gastrointestinal safety of etodolac: selective sparing of cytoprotective prostaglandins |
Q35132201 | Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. |
Q54061012 | Topical prostaglandin E2 protects isolated gastric mucosa against acidified taurocholate-, but not ethanol- or aspirin-induced injury. |
Q44072323 | Transmucosal electrical resistance in rabbit isolated gastric mucosa during exposure to acid |
Q93631220 | Ultrastructural effects of ulcerogens |
Q70275639 | Ultrastructure of tight junctions in prostaglandin-exposed rat stomach |
Q35195559 | Yu Ping Feng San, an ancient Chinese herbal decoction, regulates the expression of inducible nitric oxide synthase and cyclooxygenase-2 and the activity of intestinal alkaline phosphatase in cultures |
Q69877626 | [Isolated human gastric mucosa cells--studies on physiologic and pharmacologic regulatory mechanisms] |
Search more.